Personalized treatment of methotrexate in Crohn*s disease through therapeutic drug monitoring and prediction of clinical outcome: a known drug revisited
Completed
- Conditions
- 'Crohn's disease''inflammatory bowel diesease'10017969
- Registration Number
- NL-OMON50118
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Adults (18 years or older) with Crohn's disease starting with methotrexate as
primary drug.
Exclusion Criteria
- Cotreatment with biologicals at methotrexate start
- Not eligible to receive methotrexate as in usual care
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method